| 英文别名 |
CRID3 sodium salt;MCC950(CP-456773) sodium;CP456773 sodium;CP-456773 sodium;CRID-3 sodium salt;MCC-950 sodium;CRID3;Cytokine release inhibitory drug 3;MCC950;N-[[(1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)amino]carbonyl]-4-(1-hydroxy-1-methylethyl)-2-furansulfonamide sodium salt;MCC950 (sodium);MCC950 sodium;MCC950 sodium salt;AOB6854;MCC 950;BCP16648;s7809;AK547693;sodium;1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl-[4-(2-hydroxypropan-2-yl);MCC 950 sodium;MCC 950 sodium;sodium 1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl-[[4-(1-hydroxy-1-methyl-ethyl)-2-furyl]sulfonyl]azanide;sodium 1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl-[[4-(1-hydroxy-1-methyl-ethyl)-2-furyl]sulfonyl]azanide;CHEMBL4750616;CHEMBL4750616;Sodium (1,2,3,5,6,7-hexahydros-indacen-4-ylcarbamoyl)(4-(2-hydroxypropan-2-yl)furan-2-ylsulfonyl)amide;Sodium (1,2,3,5,6,7-hexahydros-indacen-4-ylcarbamoyl)(4-(2-hydroxypropan-2-yl)furan-2-ylsulfonyl)amide;UNII-66BL55B687;UNII-66BL55B687;AS-16974;AS-16974;BDBM50553900;BDBM50553900;66BL55B687;66BL55B687;MCC-950 sodium salt;MCC-950 sodium salt;CP-456,773 sodium salt;CP-456,773 sodium salt;AC-31714;AC-31714;BM163575;BM163575;AKOS025147369;AKOS025147369;MCC950 (CP-456773) sodium?;MCC950 (CP-456773) sodium?;DA-55278;DA-55278;Z2083055174;Z2083055174;Sodium ((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)((4-(2-hydroxypropan-2-yl)furan-2-yl)sulfonyl)amide;Sodium ((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)((4-(2-hydroxypropan-2-yl)furan-2-yl)sulfonyl)amide;Sodium((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)((4-(2-hydroxypropan-2-yl)furan-2-yl)sulfonyl)amide;Sodium((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)((4-(2-hydroxypropan-2-yl)furan-2-yl)sulfonyl)amide;((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)((4-(2-hydroxypropan-2-yl)furan-2-yl)sulfonyl)amide sodium salt;((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)((4-(2-hydroxypropan-2-yl)furan-2-yl)sulfonyl)amide sodium salt;256373-96-3;256373-96-3;sodium;1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl-[4-(2-hydroxypropan-2-yl)furan-2-yl]sulfonylazanide;sodium;1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyl-[4-(2-hydroxypropan-2-yl)furan-2-yl]sulfonylazanide;CP-456773 sodium salt;CP-456773 sodium salt;EN300-214108;EN300-214108;CS-5427;CP456773;CS-5427;MCC950(CP-456773);CP456773;CCG-268961;MCC950(CP-456773);J-690261;CCG-268961;256373-96-3 (sodium);J-690261;HY-12815A;256373-96-3 (sodium);MCC 950 Sodium Salt;HY-12815A;MFCD30478884;MCC 950 Sodium Salt;EX-A2838;MFCD30478884;CP-456773 sodium salt, >=98% (HPLC);EX-A2838;M3396;CP-456773 sodium salt, >=98% (HPLC);AKOS027470193;M3396;2-Furansulfonamide, N-(((1,2,3,5,6,7-hexahydro-S-indacen-4-yl)amino)carbonyl)-4-(1-hydroxy-1-methylethyl)-, monosodium salt;AKOS027470193;sodium [(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl][4-(2-hydroxypropan-2-yl)furan-2-ylsulfonyl]azanide;2-Furansulfonamide, N-(((1,2,3,5,6,7-hexahydro-S-in... |